Mark E. Molitch
Impact in
- Endocrinology, Diabetes and Metabolism top 0.01%
- Pituitary Gland Disorders and Treatments
- Growth Hormone and Insulin-like Growth Factors
- Hormonal and reproductive studies
- Diabetes Treatment and Management
- Diabetes Management and Research
- Adrenal Hormones and Disorders
- Nephrology top 0.1%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Pituitary Gland Disorders and Treatments 179
- Growth Hormone and Insulin-like Growth Factors 125
- Diabetes Treatment and Management 45
- Diabetes Management and Research 39
- Nephrology 37
- Chronic Kidney Disease and Diabetes 28
- Co-authors
- George L. Bakris (12 shared papers)Shlomo Melmed (15 shared papers)Laurence J. Katznelson (4 shared papers)Mary Lee Vance (7 shared papers)Edward R. Laws (4 shared papers)David R. Clemmons (7 shared papers)Mohammad Hassan Murad (2 shared papers)John A. H. Wass (4 shared papers)
- Journals
- The Journal of Clinical Endocrinology & Metabolism (45 papers)Diabetes Care (42 papers)Pituitary (19 papers)Endocrine Practice (13 papers)JAMA (13 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Mark E. Molitch
400 papers receiving 26.7k citations
Mark E. Molitch's Hit Papers
Peers
Comparison fields: 5 of 170
- Endocrinology, Diabetes and Metabolism 17.4k
- Nephrology 3.3k
- Genetics 1.3k
- Surgery 5.1k
- Reproductive Medicine 801
Countries citing papers authored by Mark E. Molitch
This map shows the geographic impact of Mark E. Molitch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Molitch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Molitch more than expected).
Fields of papers citing papers by Mark E. Molitch
This network shows the impact of papers produced by Mark E. Molitch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Molitch. The network helps show where Mark E. Molitch may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Molitch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 423 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Acromegaly: An Endocrine Society Clinical Practice Guideline Hit paper breakdown → | 2014 | 1365 |
| 2 | Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease Hit paper breakdown → | 2006 | 1240 |
| 3 | Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association Hit paper breakdown → | 2019 | 961 |
| 4 | Diabetic Kidney Disease: A Report From an ADA Consensus Conference Hit paper breakdown → | 2014 | 876 |
| 5 | Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline Hit paper breakdown → | 2011 | 720 |
| 6 | Diabetic Kidney Disease: A Report From an ADA Consensus Conference Hit paper breakdown → | 2014 | 716 |
| 7 | Diagnosis and Treatment of Pituitary Adenomas Hit paper breakdown → | 2017 | 707 |
| 8 | Effects of Testosterone Treatment in Older Men Hit paper breakdown → | 2016 | 673 |
| 9 | Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas Hit paper breakdown → | 2006 | 623 |
| 10 | Guidelines for Acromegaly Management: An Update Hit paper breakdown → | 2009 | 614 |
| 11 | Advances in the Treatment of Prolactinomas Hit paper breakdown → | 2006 | 614 |
| 12 | 2011 | 414 | |
| 13 | Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome Hit paper breakdown → | 2012 | 399 |
| 14 | Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline Hit paper breakdown → | 2019 | 379 |
| 15 | 1985 | 343 | |
| 16 | 2006 | 314 | |
| 17 | Consensus on diagnosis and management of Cushing's disease: a guideline update Hit paper breakdown → | 2021 | 307 |
| 18 | 2017 | 305 | |
| 19 | Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes Hit paper breakdown → | 2020 | 282 |
| 20 | Multidisciplinary management of acromegaly: A consensus Hit paper breakdown → | 2020 | 265 |
About Mark E. Molitch
Mark E. Molitch is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Surgery, Genetics and Physiology, having authored 423 papers that have together received 28.5k indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (179 papers), Growth Hormone and Insulin-like Growth Factors (125 papers), Adrenal and Paraganglionic Tumors (56 papers), Diabetes Treatment and Management (45 papers), Diabetes Management and Research (39 papers), Chronic Kidney Disease and Diabetes (28 papers), Neuroendocrine Tumor Research Advances (26 papers) and Glioma Diagnosis and Treatment (23 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (17.4k citations), Nephrology (3.3k citations), Genetics (1.3k citations), Surgery (5.1k citations) and Reproductive Medicine (801 citations). Mark E. Molitch has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include George L. Bakris, Shlomo Melmed, Laurence J. Katznelson, Mary Lee Vance, Edward R. Laws, David R. Clemmons, Mohammad Hassan Murad, John A. H. Wass, Mary P. Gillam and George R. Merriam. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care, Pituitary, Endocrine Practice and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.